Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Rodger

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
BMJ Open|December 1, 2018
Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant dataPhilippe Robin, Maggie Eddy, Lindsey Sikora, et al.
Journal of Thrombosis and Haemostasis : JTH|January 23, 2025
Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolismOhanna C L Bezerra, Marc Rodger, Gaëlle Munsch, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 30, 2018
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic reviewSake J van der Wall, Liselotte M van der Pol, Yvonne M Ende-Verhaar, et al.
Journal of Thrombosis and Haemostasis : JTH|August 13, 2019
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSCBernard Tardy, Emilie Chalayer, Pieter Willem Kamphuisen, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 14, 2014
Venous thromboembolism and antithrombotic therapy in pregnancyWee-Shian Chan, Evelyne Rey, Nancy E Kent, et al.
Plos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.
Thrombosis and Haemostasis|June 29, 2007
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trialKarim Abou-Nassar, Michael J Kovacs, Susan R Kahn, et al.
Thrombosis Research|October 6, 2023
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort studyYan Xu, Faizan Khan, Michael J Kovacs, et al.
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
Thrombosis Research|June 13, 2016
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two dosesSuzanne M Bleker, Andrea Buchmüller, Céline Chauleur, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
BMJ Open|December 1, 2018
Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant dataPhilippe Robin, Maggie Eddy, Lindsey Sikora, et al.
Journal of Thrombosis and Haemostasis : JTH|January 23, 2025
Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolismOhanna C L Bezerra, Marc Rodger, Gaëlle Munsch, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 30, 2018
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic reviewSake J van der Wall, Liselotte M van der Pol, Yvonne M Ende-Verhaar, et al.
Journal of Thrombosis and Haemostasis : JTH|August 13, 2019
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSCBernard Tardy, Emilie Chalayer, Pieter Willem Kamphuisen, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 14, 2014
Venous thromboembolism and antithrombotic therapy in pregnancyWee-Shian Chan, Evelyne Rey, Nancy E Kent, et al.
Plos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.
Thrombosis and Haemostasis|June 29, 2007
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trialKarim Abou-Nassar, Michael J Kovacs, Susan R Kahn, et al.
Thrombosis Research|October 6, 2023
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort studyYan Xu, Faizan Khan, Michael J Kovacs, et al.
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
Thrombosis Research|June 13, 2016
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two dosesSuzanne M Bleker, Andrea Buchmüller, Céline Chauleur, et al.
Pageof 10